NCT06030986

Brief Summary

In the course of prehospital respiratory and circulatory arrest, approximately 1000 persons are resuscitated by cardiopulmonary resuscitation in Upper Austria every year. Despite constant further development of methods, equipment and continuous training of the rescue and emergency medical teams working on site, the majority of patients who have to be resuscitated prehospital still die. However, even patients whose circulatory function can be restored during prehospital resuscitation (Return of Spontaneous Circulation, ROSC) require intensive medical care for days to weeks and often find it very difficult to return to a normal, independent life. The success of resuscitation measures depends on the quality of the resuscitation performed as well as on patient-specific factors. Evaluation scales such as the Cerebral Performance Category score (CPC) allow a posteriori assessment of resuscitation success. Nowadays, it is very difficult to estimate the outcome of resuscitation a priori. In many cases, it is not at all clear at the beginning of the treatment pathway whether the individual patient is expected to have an unfavorable prognosis in the context of respiratory arrest or whether a restitutio ad integrum is possible. Thus, the decision to continue or discontinue resuscitation can only be made on the basis of an individual physician's assessment. In addition to the primary concern of stopping resuscitation too early, there is also the risk that medical resources are used beyond the normal level after resuscitation without expecting a successful outcome. Estimating and categorizing the subsequent outcome is difficult and emotionally stressful for the treating team in the acute situation. Some factors that influence outcome are now known: As cerebral hypoperfusion increases, the probability of survival decreases sharply with each passing minute. In this context, potentially reversible causes have been identified in different works, allowing causal therapy to improve neurological outcome. In addition to the most important therapy bridging hypoperfusion, chest compression, with the aim of ensuring minimal perfusion of the brain, immediate defibrillation should be mentioned in particular, which now allows medical laypersons to use defibrillators as part of the Public Access Defibrillation Network. Despite all efforts, however, it is not yet possible to make reliable statements about the probable outcome of persons with respiratory and circulatory arrest with a high degree of certainty in a large number of cases at an early stage. Artificial intelligence refers to the ability of machines to perform cognitive tasks, such as recognizing objects in images and classifying them. For a long time, many processes were too complex to explore through sufficient computing power, storage capacity, and understanding. More recently, however, technological advances have brought machine learning (ML) and the constructs behind it, including those based on so-called neural networks (known since about 1950), back to the fore. Not only the development of theoretical models, but after extensive testing also devices applicable in daily routine operation are available. Modern machine learning methods are enabling a variety of new approaches to assessing operations, including modeling complex systems and finding relationships between models.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Dec 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress40%
Dec 2025Dec 2026

First Submitted

Initial submission to the registry

September 3, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 11, 2023

Completed
2.2 years until next milestone

Study Start

First participant enrolled

December 1, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

July 3, 2025

Status Verified

October 1, 2024

Enrollment Period

7 months

First QC Date

September 3, 2023

Last Update Submit

June 30, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • AUC-ROC for Prediction of ILCOR Utstein OHCA Core Outcome

    AUC-ROC for Prediction of ILCOR Utstein OHCA Core Outcome

    2015-01-01 - 2023-10-31

  • AUC-PRC for Prediction of ILCOR Utstein OHCA Core Outcome

    AUC-PRC for Prediction of ILCOR Utstein OHCA Core Outcome

    2015-01-01 - 2023-10-31

  • F1-Score for Prediction of ILCOR Utstein OHCA Core Outcome

    F1-Score for Prediction of ILCOR Utstein OHCA Core Outcome

    2015-01-01 - 2023-10-31

  • Confusion Matrix for Prediction of ILCOR Utstein OHCA Core Outcome

    Confusion Matrix for Prediction of ILCOR Utstein OHCA Core Outcome

    2015-01-01 to 2023-10-31

Secondary Outcomes (4)

  • AUC-ROC for Prediction of Diagnosis at Hospital Discharge

    2015-01-01 - 2023-10-31

  • AUC-PRC for Prediction of Diagnosis at Hospital Discharge

    2015-01-01 - 2023-10-31

  • F1-Score for Prediction of Diagnosis at Hospital Discharge

    2015-01-01 - 2023-10-31

  • Confusion Matrix for Prediction of Diagnosis at Hospital Discharge

    2015-01-01 - 2023-10-31

Study Arms (2)

ILCOR Utstein OHCA Core Outcome Positive

Respectively for all core outcomes defined.

Diagnostic Test: ILCOR Utstein OHCA Core Outcome

ILCOR Utstein OHCA Core Outcome Negative

Respectively for all core outcomes defined.

Diagnostic Test: ILCOR Utstein OHCA Core Outcome

Interventions

ILCOR Utstein OHCA Core Outcome

ILCOR Utstein OHCA Core Outcome NegativeILCOR Utstein OHCA Core Outcome Positive

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

As described in the inclusion criteria.

You may qualify if:

  • Patients 18 years or older AND
  • between 2015-01-01 and 2023-10-31 AND
  • have been treated by emergency medical teams of the Austrian Red Cross, District Branch of Upper Austria AND
  • have suffered out-of-hospital cardiac arrest AND
  • have been treated by emergency physicians while out of hospital AND
  • have been transported to the Kepler University Hospital, Linz, Austria

You may not qualify if:

  • \- none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kepler University Hospital

Linz, Upper Austria, 4020, Austria

Location

MeSH Terms

Conditions

Heart Arrest

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Central Study Contacts

Thomas Tschoellitsch, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 3, 2023

First Posted

September 11, 2023

Study Start

December 1, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

July 3, 2025

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations